Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Exercise medicine

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44347   clinical trials with a EudraCT protocol, of which   7375   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    58 result(s) found for: Exercise medicine. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2011-003652-39 Sponsor Protocol Number: 30689 Start Date*: 2012-09-17
    Sponsor Name:Karen Schow Jensen
    Full Title: Exercise induced bronchoconstriction in children – a single dose of montelukast as alternative to regular daily doses.
    Medical condition: Exercise induced asthma
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004855 10015649 Exercise induced asthma LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2016-000573-20 Sponsor Protocol Number: 1.0 Start Date*: 2016-06-14
    Sponsor Name:Department of Sports Medicine, Institute for Sport Sciences, Justu-Liebig-University of Gießen
    Full Title: Effects of MUTAFLOR® on exercise-induced gastro-intestinal dysfunction
    Medical condition: To investigate the effects of Mutaflor® Suspension on exercise induced gastrointestinal symptoms for 3 hours after a strenous exercise test on a treadmill
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-016904-21 Sponsor Protocol Number: SD-MLK Start Date*: 2010-04-22
    Sponsor Name:Medisch Spectrum Twente
    Full Title: The predictive value of the acute effect of montelukast on an exercise challenge test for the outcome of longterm treatment with montelukast
    Medical condition: Exercise induced asthma / bronchoconstriction Asthma
    Disease: Version SOC Term Classification Code Term Level
    12.0 10015649 Exercise induced asthma LLT
    12.0 10066091 Bronchial hyperreactivity LLT
    12.0 10003553 Asthma PT
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-018937-23 Sponsor Protocol Number: SD-QVAR Start Date*: 2010-05-31
    Sponsor Name:Medisch Spectrum Twente
    Full Title: The predictive value of the acute effect of beclomethasone on a mannitol challenge test for the outcome of lomgterm treatment with beclomethasone
    Medical condition: Exercise induced asthma / bronchoconstriction Asthma
    Disease: Version SOC Term Classification Code Term Level
    12.1 10015649 Exercise induced asthma LLT
    12.1 10003553 Asthma PT
    12.1 10066091 Bronchial hyperreactivity PT
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2011-002987-26 Sponsor Protocol Number: KOLterbutaline Start Date*: 2011-08-24
    Sponsor Name:Bispebjerg Hospital
    Full Title: Effects of high dose terbutaline on physical performance in patients with chronic obstructive pulmonary disease and acute inflammatory response after exercise
    Medical condition: To investigate the effects of terbutaline on repeated exercise performance in patients with chronic obstructive pulmonary disease (COPD). Furthermore to examine the inflammatory response during and...
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2014-004872-47 Sponsor Protocol Number: NSAID2015 Start Date*: 2015-07-20
    Sponsor Name:Karolinska Institutet, Department of Laboratory Medicine, Clinical Physiology C1:82,Karolinska Univ. Hosp., Huddinge
    Full Title: The effects of COX-inhibiting drugs on skeletal muscle adaptations to resistance exercise in healthy adults.
    Medical condition: Human skeletal muscle adaptations to resistance exercise (non-disease related).
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2019-001281-14 Sponsor Protocol Number: Protocol_NN-ExFiasp_V_5.3 Start Date*: 2019-06-18
    Sponsor Name:Medical University of Graz
    Full Title: A trial investigating the effect on blood glucose after the injection of fast-acting insulin aspart (Fiasp®) in comparison to insulin aspart (NovoRapid®) around exercise in participants with type 1...
    Medical condition: Type 1 Diabetes
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004861 10045228 Type I diabetes mellitus LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-002804-42 Sponsor Protocol Number: Beta2-Mikro Start Date*: 2012-09-10
    Sponsor Name:Bispebjerg Hospital
    Full Title: The effects of high dose beta2-agonists on physical performance in healthy male subjects
    Medical condition: No medical condition will be investigated. To examine the effects of beta2-agonists on aerobic and anaerobic exercise performance.
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: DK (Prematurely Ended)
    Trial results: Removed from public view
    EudraCT Number: 2012-004503-13 Sponsor Protocol Number: KOLprednisolone Start Date*: 2012-12-12
    Sponsor Name:Bispebjerg Hospital
    Full Title: Effect of Glococorticosteroids on physical performance in patients with chronic obstructive pulmonary disease and acute inflammatory response after exercise
    Medical condition: To investigate the effects of prednisone and Solu-Medrol on physical performance in patients with chronic obstructive pulmonary disease(COPD). Furthermore to examine the inflammatory response durin...
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-004393-10 Sponsor Protocol Number: GN18CA068 Start Date*: 2019-07-17
    Sponsor Name:NHS Greater Glasgow & Clyde [...]
    1. NHS Greater Glasgow & Clyde
    2. University of Glasgow
    Full Title: A randomised, double-blind, placebo-controlled, cross-over trial of zibotentan in microvascular angina
    Medical condition: Microvascular Angina and impaired exercise intolerance.
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004849 10065566 Microvascular angina LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2013-004631-77 Sponsor Protocol Number: EX21102013 Start Date*: 2014-01-24
    Sponsor Name:Medizinische Universität Graz/Endokrinologie und Stoffwechsel
    Full Title: Exercise and Blood Glucose Levels in Patients with Type I Diabetes - a Pilot Study
    Medical condition: Type 1 diabetes
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2019-003209-89 Sponsor Protocol Number: ULTRAFLEXI1 Start Date*: 2019-12-12
    Sponsor Name:Medical University of Graz
    Full Title: A trial investigating ultra-long-acting basal insulins’ flexibility around multiple spontaneous exercise sessions in people with type 1 diabetes: a head to head comparison of 2nd generation insulin...
    Medical condition: Type 1 Diabetes
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004861 10045228 Type I diabetes mellitus LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2015-000462-62 Sponsor Protocol Number: Statex1 Start Date*: 2015-09-23
    Sponsor Name:Radboud university medical centre
    Full Title: The effects of statins on skeletal muscle mitochondria: is exercise the medicine?
    Medical condition: Asymp and symp statin users will undergo baseline measurements of skeletal muscle mitochondrial function and muscle function after which they will be switched to a single-blind placebo intervention...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2009-012621-12 Sponsor Protocol Number: R&D2008GR03 Start Date*: 2009-08-06
    Sponsor Name:University of Dundee
    Full Title: Maximising physical function in later life: a 2 centre randomised trial of progressive resistance exercise training in combination with ACE inhibition
    Medical condition: Age related decline in muscle function (sarcopenia)
    Disease: Version SOC Term Classification Code Term Level
    13.1 10028395 - Musculoskeletal and connective tissue disorders 10063024 Sarcopenia PT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2013-000483-29 Sponsor Protocol Number: Wada_2012 Start Date*: 2013-07-17
    Sponsor Name:Bispebjerg Hospital
    Full Title: The influence of exercise and hydration to the pharmacological response to inhaled terbutalin and salbutamol in men
    Medical condition: To investigate the pharmacokinetic effect of the medicine under physical work in healthy men
    Disease: Version SOC Term Classification Code Term Level
    16.1 10022891 - Investigations 10022891 Investigations SOC
    Population Age: Adults Gender: Male
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2004-002754-62 Sponsor Protocol Number: 2004-001 Start Date*: 2006-06-20
    Sponsor Name:University of Göttingen; Dep. of Clinical Pharmacology
    Full Title: Development of CYP2D6 genotype based dosage guidelines for the beta-blockers metoprolol and carvedilol based on hepatic clearance and resting and exercise heart rate reduction
    Medical condition: Healthy male and female volunteers
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2018-002590-22 Sponsor Protocol Number: NN9924-4338 Start Date*: 2019-07-25
    Sponsor Name:Novo Nordisk A/S
    Full Title: China multi-regional clinical trial: Efficacy and safety of oral semaglutide versus placebo in subjects with type 2 diabetes mellitus treated with diet and exercise only
    Medical condition: Diabetes Mellitus, Type 2
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004861 10045242 Type II diabetes mellitus LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed)
    Trial results: View results
    EudraCT Number: 2018-004882-15 Sponsor Protocol Number: EntREG-SILICOFCM Start Date*: 2019-05-21
    Sponsor Name:University Hospital Regensburg
    Full Title: Effect of angiotensin receptor neprilysin inhibitor sacubitril/valsartan on cardiopulmonary exercise tolerance in patients with hypertrophic cardiomyopathy – a randomized controlled clinical Phase ...
    Medical condition: hypertrophic cardiomyopathy
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-017011-16 Sponsor Protocol Number: 0000000000000000000 Start Date*: 2011-06-16
    Sponsor Name:University Federico II
    Full Title: Treatment of the low IGF-1 syndrome associated with Chronic Heart Failure: A Randomized, Placebo-Controlled, Double-Blind Study
    Medical condition: Low serum IGF-I and GH deficiency in patients with congestive heart failure
    Disease:
    Population Age: Adults, Elderly Gender:
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-001250-41 Sponsor Protocol Number: KOLD Start Date*: 2015-04-15
    Sponsor Name:Region Östergötland
    Full Title: THE IMPACT OF VITAMIN D ON PHYSICAL TRAINING OF VITAMIN D DEFICIENT PATIENTS WITH COPD: A PROSPECTIVE RANDOMIZED PLACEBO-CONTROLLED DOUBLE-BLIND MULTI-CENTRE STUDY
    Medical condition: Patients with chronic obstructive pulmonary disease (COPD) and concomitant vitamin D deficiency
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Tue Jul 08 04:42:46 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA